At SLAS2024, Aspen Biosciences, a provider of custom software, and integrations for drug discovery companies, has announced the launch of Pipeline, a drug discovery program management software platform.
Pipeline has been purpose-built to address the intricate coordination of high-volume data management required in drug discovery endeavors. The platform streamlines an array of pivotal tasks including target identification, protein production, assay management, as well as compound and biological registration. Beyond its operational capabilities, Pipeline provides dashboards that give a comprehensive overview of a program's progress, potential impediments, resource allocation, and financial oversight.
Embracing the pillars of the FAIR guidelines – findability, accessibility, interoperability, and reusability – Pipeline champions the standardization of scientific data across various stages of drug discovery projects.
Mark Fortner, founder and CEO, said, “Our intention with Pipeline was to forge a pathway for research teams to enhance their operational efficiency dramatically. Conceived and brought to life by scientists themselves, the platform has already garnered enthusiastic feedback from our early reviewers.”